Research in colorectal cancer has revealed that PTPRO can associate with erb-b2 receptor tyrosine kinase 2 (ERBB2), thereby inhibiting signaling pathways and obstructing tumor growth [255]. This evidence concerns the gene ERBB2 and neoplasm.